estrogeenikorvaushoito

Estrogeenikorvaushoito, often abbreviated as EKH or HRT (Hormone Replacement Therapy) in English, is a medical treatment used to alleviate symptoms associated with the decline of estrogen levels in the body, primarily during menopause. It involves administering estrogen, and sometimes progesterone, to supplement the body's natural production.

The primary indication for estrogeenikorvaushoito is the management of menopausal symptoms. These can include hot flashes, vaginal dryness, sleep disturbances, and mood swings. For women who have undergone surgical removal of the ovaries before natural menopause, EKH can also prevent premature bone loss and other long-term health consequences.

Estrogeenikorvaushoito can be administered in various forms, including oral tablets, skin patches, gels, sprays, and vaginal creams or rings. The choice of administration method and the specific hormones used depend on individual needs, medical history, and treatment goals. If a woman still has her uterus, a combination therapy including progesterone is typically prescribed to protect the uterine lining from overgrowth, which can increase the risk of endometrial cancer.

While estrogeenikorvaushoito can be highly effective in managing menopausal symptoms and improving quality of life, it also carries potential risks. These may include an increased risk of blood clots, stroke, and certain types of cancer, although the absolute risk is generally considered low for most healthy women initiating treatment around the time of menopause. The decision to start estrogeenikorvaushoito should be made in consultation with a healthcare professional who can assess individual benefits and risks. Regular medical follow-up is essential to monitor the treatment's effectiveness and safety.